The total return over the past 12 months is -6.38% vs. +16.94% for the S&P 500. So far it's up +12.41% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (6.38%) | (13.01%) | (1.82%) | +5.07% | +1.94% | (2.63%) |
| Total Return CAGR | (6.38%) | (13.01%) | (1.82%) | +5.07% | +1.94% | (2.63%) |
| Revenue CAGR | +4.69% | +9.16% | +12.04% | +8.94% | +0.60% | +4.73% |
| Net Income CAGR | (304.94%) | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | (310.74%) | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | (85.46%) | +69.62% | (34.62%) | (0.35%) | (5.40%) | N/A |
| Operating Cash Flow CAGR | (70.10%) | +26.69% | (23.67%) | +5.49% | (1.85%) | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Ultralife Corporation (ULBI)
| Year | Start price | End price | ULBI Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $5.72 | $6.43 | +12.41% | +14.51% | (2.10%) |
| 2025 | $7.45 | $5.72 | (23.22%) | +17.72% | (40.94%) |
| 2024 | $6.82 | $7.45 | +9.24% | +24.89% | (15.65%) |
| 2023 | $3.86 | $6.82 | +76.68% | +26.19% | +50.49% |
| 2022 | $6.04 | $3.86 | (36.09%) | (18.17%) | (17.92%) |
| 2021 | $6.47 | $6.04 | (6.65%) | +28.74% | (35.39%) |
| 2020 | $7.39 | $6.47 | (12.45%) | +18.37% | (30.82%) |
| 2019 | $6.75 | $7.39 | +9.48% | +31.22% | (21.74%) |
| 2018 | $6.55 | $6.75 | +3.05% | (4.56%) | +7.61% |
| 2017 | $4.95 | $6.55 | +32.32% | +21.70% | +10.62% |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
